The Health Research Institute Hospital 12 de Octubre, commonly known by its Spanish acronym imas12 (Instituto de Investigación Sanitaria Hospital 12 de Octubre), is a leading biomedical research institution located in Madrid, Spain. Affiliated with the Hospital Universitario 12 de Octubre, one of the largest public hospitals in the Madrid region, imas12 serves as a hub for translational research, connecting basic scientific discovery with clinical application and patient care.
Accredited by the Instituto de Salud Carlos III (ISCIII), the institute operates within the framework of Spain's national network of health research institutes. Its mission is to advance the understanding, prevention, diagnosis, and treatment of disease through high-quality scientific research, while fostering collaboration between clinicians, basic scientists, and academic partners.
Institutional Framework and Partnerships
imas12 is the result of a strategic collaboration between several key institutions in the Madrid research and healthcare ecosystem. Its primary partners include:
- Hospital Universitario 12 de Octubre, providing the clinical setting and access to a large patient population.
- Universidad Complutense de Madrid (UCM), contributing academic expertise, teaching capacity, and research talent.
- The ConsejerÃa de Sanidad de la Comunidad de Madrid (the regional health authority), which supports and oversees public health research initiatives.
This integration allows the institute to align its scientific priorities with genuine clinical needs, ensuring that research findings can be translated efficiently into improvements in patient outcomes.
Research Focus and Scientific Areas
The institute organizes its activities around a series of research programs and groups that span a wide range of medical disciplines. The main areas of focus include:
Oncology and Cancer Research
Investigation into the molecular mechanisms of cancer, tumor biology, hematological malignancies, solid tumors, and the development of novel therapeutic strategies including targeted therapies and immunotherapy. Clinical trials for new anticancer agents are a significant component of this work.
Infectious Diseases and Immunity
Research on viral, bacterial, and other infectious agents, including studies on HIV, hepatitis, tuberculosis, and emerging pathogens. This area also encompasses immunology, host-pathogen interactions, and vaccine-related research.
Cardiovascular and Respiratory Diseases
Studies addressing heart disease, hypertension, pulmonary conditions, and related chronic disorders, with an emphasis on prevention, early diagnosis, and improved treatment protocols.
Neurosciences
Research into neurological and neurodegenerative disorders, brain function, and conditions affecting the central and peripheral nervous systems.
Nephrology and Transplantation
Given the hospital's strong reputation in organ transplantation, the institute conducts extensive research in renal disease, transplant immunology, organ preservation, and post-transplant patient management.
Pediatrics and Rare Diseases
Investigation into childhood illnesses, congenital conditions, and rare diseases, including genetic and metabolic disorders that require specialized study.
Chronic and Systemic Diseases
Research on metabolic conditions, endocrine disorders, autoimmune diseases, and other systemic illnesses affecting large patient populations.
Products and Services
While imas12 is fundamentally a research institution rather than a commercial company, it offers a range of services and outputs that support the broader scientific and healthcare community. These include:
Clinical Trials Management
The institute provides infrastructure and support for the design, coordination, and execution of clinical trials across multiple phases. This includes regulatory support, ethics committee coordination, patient recruitment, and data management, making it an attractive partner for pharmaceutical companies, biotechnology firms, and academic sponsors.
Scientific and Technical Platforms
imas12 maintains advanced technological platforms and core facilities that are available to researchers. These typically include genomics and molecular biology services, cytometry and cell analysis, microscopy and imaging, biobanking, and bioinformatics support. These shared resources enable high-quality experimental work and provide services to internal and external users.
Biobank Services
The institute operates a biobank for the collection, processing, storage, and distribution of biological samples for research purposes, in accordance with ethical and legal standards. This resource is essential for translational and epidemiological studies.
Research Support and Management
imas12 offers comprehensive administrative and management support to its research groups, including assistance with grant applications, project management, financial administration, and compliance with national and international funding requirements.
Innovation and Technology Transfer
The institute promotes the transfer of research results to the productive sector through the protection of intellectual property, the development of patents, and the facilitation of collaborations with industry. It supports the creation of spin-off companies and the commercialization of innovations arising from its research.
Training and Education
As an academic institution linked to the Universidad Complutense de Madrid, imas12 contributes to the training of researchers, doctoral students, and healthcare professionals. It hosts training programs, seminars, and scientific events, supporting the development of the next generation of biomedical scientists.
Approach to Translational Medicine
A defining characteristic of imas12 is its commitment to translational research, an approach that seeks to bridge the gap between laboratory discoveries and clinical practice. By embedding research activities within a major hospital environment, the institute ensures that scientific investigations remain closely tied to real-world medical challenges. This proximity between researchers and clinicians accelerates the movement of knowledge from bench to bedside, ultimately aiming to improve diagnostic accuracy, therapeutic effectiveness, and quality of life for patients.
Collaboration and Networks
imas12 participates in numerous collaborative networks at the regional, national, and international levels. It engages with other research institutes, universities, and hospitals, as well as with cooperative research networks funded by the Instituto de Salud Carlos III, such as thematic networks (CIBER) dedicated to specific disease areas. These collaborations enhance the scope and impact of its research and provide access to shared expertise, funding, and resources.
Significance
As one of the accredited health research institutes in Spain, imas12 plays an important role in the country's biomedical research landscape. Its combination of clinical excellence, academic strength, and research infrastructure positions it as a significant contributor to advances in medicine. Through its work in oncology, infectious diseases, transplantation, and many other fields, the institute supports the continuous improvement of healthcare, both within the Madrid region and beyond.
Summary
The Health Research Institute Hospital 12 de Octubre (imas12) is a Madrid-based biomedical research center dedicated to translational and clinical research. Backed by the Hospital Universitario 12 de Octubre, the Universidad Complutense de Madrid, and the regional health authority, it conducts research across a broad spectrum of medical disciplines. Its services encompass clinical trials management, scientific platforms, biobanking, innovation and technology transfer, and training, all aimed at transforming scientific discovery into tangible benefits for patients and society.
